{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for mycophenolic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:maridebart cafraglutide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04381936: Phase 3 Interventional Recruiting Severe Acute Respiratory Syndrome
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04381936: Phase 3 Interventional Recruiting Severe Acute Respiratory Syndrome
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04718389: Phase 3 Interventional Active, not recruiting Asthma
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04570267: Phase 1 Interventional Completed Healthy
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:nivatrotamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04515927: Phase 2 Interventional Completed Hyperlipemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pelgifatamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:alcestobart [INN]
Source URL:
Class:
PROTEIN
